427 related articles for article (PubMed ID: 23003329)
1. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
[TBL] [Abstract][Full Text] [Related]
2. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
[TBL] [Abstract][Full Text] [Related]
3. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
4. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
[TBL] [Abstract][Full Text] [Related]
5. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
6. Should the amounts of fat and protein be taken into consideration to calculate the lunch prandial insulin bolus? Results from a randomized crossover trial.
García-López JM; González-Rodriguez M; Pazos-Couselo M; Gude F; Prieto-Tenreiro A; Casanueva F
Diabetes Technol Ther; 2013 Feb; 15(2):166-71. PubMed ID: 23259764
[TBL] [Abstract][Full Text] [Related]
7. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
[TBL] [Abstract][Full Text] [Related]
8. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
[TBL] [Abstract][Full Text] [Related]
9. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
10. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
11. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
[TBL] [Abstract][Full Text] [Related]
12. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
Rodbard D; Jovanovic L; Garg SK
Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
[TBL] [Abstract][Full Text] [Related]
13. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
14. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB
Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684
[TBL] [Abstract][Full Text] [Related]
15. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
Bragd J; von Döbeln A; Lins PE; Adamson U; Bergström J; Oskarsson P
Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
[TBL] [Abstract][Full Text] [Related]
16. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
Heptulla RA; Allen HF; Gross TM; Reiter EO
Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
[TBL] [Abstract][Full Text] [Related]
17. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
[TBL] [Abstract][Full Text] [Related]
18. Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.
Hovorka R; Nodale M; Haidar A; Wilinska ME
Diabetes Technol Ther; 2013 Jan; 15(1):4-12. PubMed ID: 23046396
[TBL] [Abstract][Full Text] [Related]
19. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
